Moreover, Zhen et al. reported that blocking IFNAR2 during the chronic phase of HIV infection led to decreased viral replication, diminished HIV-1-driven immune activation, and restored HIV-1 specific CD8+ T cell function [72]. Here, IFNAR2 is linked to HIV infectious disease.